No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Asparaginase / administration & dosage
-
Asparaginase / adverse effects
-
Child
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects
-
Daunorubicin / administration & dosage
-
Daunorubicin / adverse effects
-
Humans
-
Leukemia, Myeloid, Acute / diagnostic imaging
-
Leukemia, Myeloid, Acute / drug therapy*
-
Magnetic Resonance Imaging
-
Male
-
Mercaptopurine / administration & dosage
-
Mercaptopurine / adverse effects
-
Methotrexate / administration & dosage
-
Methotrexate / adverse effects
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
Radiography
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
-
Wernicke Encephalopathy / chemically induced*
-
Wernicke Encephalopathy / diagnostic imaging
-
Wernicke Encephalopathy / drug therapy
Substances
-
Cytarabine
-
Vincristine
-
Cyclophosphamide
-
Mercaptopurine
-
Asparaginase
-
Prednisone
-
Methotrexate
-
Daunorubicin
Supplementary concepts
-
AIEOP acute lymphoblastic leukemia protocol